1. Home
  2. BLND vs VALN Comparison

BLND vs VALN Comparison

Compare BLND & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLND
  • VALN
  • Stock Information
  • Founded
  • BLND 2012
  • VALN 2012
  • Country
  • BLND United States
  • VALN France
  • Employees
  • BLND N/A
  • VALN N/A
  • Industry
  • BLND EDP Services
  • VALN Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • BLND Technology
  • VALN Health Care
  • Exchange
  • BLND Nasdaq
  • VALN Nasdaq
  • Market Cap
  • BLND 925.5M
  • VALN 777.9M
  • IPO Year
  • BLND 2021
  • VALN 2021
  • Fundamental
  • Price
  • BLND $4.31
  • VALN $8.94
  • Analyst Decision
  • BLND Buy
  • VALN Strong Buy
  • Analyst Count
  • BLND 6
  • VALN 4
  • Target Price
  • BLND $4.88
  • VALN $15.75
  • AVG Volume (30 Days)
  • BLND 3.5M
  • VALN 128.5K
  • Earning Date
  • BLND 11-05-2025
  • VALN 11-06-2025
  • Dividend Yield
  • BLND N/A
  • VALN N/A
  • EPS Growth
  • BLND N/A
  • VALN N/A
  • EPS
  • BLND N/A
  • VALN N/A
  • Revenue
  • BLND $167,776,000.00
  • VALN $230,566,060.00
  • Revenue This Year
  • BLND N/A
  • VALN $15.55
  • Revenue Next Year
  • BLND $29.08
  • VALN $23.93
  • P/E Ratio
  • BLND N/A
  • VALN N/A
  • Revenue Growth
  • BLND 29.83
  • VALN 25.47
  • 52 Week Low
  • BLND $2.64
  • VALN $3.62
  • 52 Week High
  • BLND $5.53
  • VALN $12.25
  • Technical
  • Relative Strength Index (RSI)
  • BLND 65.29
  • VALN 49.28
  • Support Level
  • BLND $4.07
  • VALN $8.33
  • Resistance Level
  • BLND $4.46
  • VALN $9.46
  • Average True Range (ATR)
  • BLND 0.26
  • VALN 0.35
  • MACD
  • BLND 0.09
  • VALN -0.15
  • Stochastic Oscillator
  • BLND 83.26
  • VALN 61.30

About BLND Blend Labs Inc.

Blend Labs Inc is a cloud-based platform software platform that powers the digital interface between financial services firms and consumers. It supports and simplifies applications for mortgages, consumer loans, and deposit accounts. Its operating segments are; Blend Platform segment which comprises a suite of products that power the entire origination process from back-end workflows to consumer experience, and the Title segment enables customers to streamline the title, settlement, and closing process at scale for mortgages, home equity lines of credit, and home equity loans. The majority of the revenue for the company is generated from the Blend Platform segment.

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Share on Social Networks: